Figures & data
Table 1. Chemerin levels in metabolic syndrome.
Stejskal, D., et al., 2008. Chemerin is an independent marker of the metabolic syndrome in a Caucasian population – a pilot study. Biomedical papers, 152 (2), 217–221. Dong, B., Ji, W., and Zhang, Y., 2011. Elevated serum chemerin levels are associated with the presence of coronary artery disease in patients with metabolic syndrome. Internal Medicine, 50 (10), 1093–1097. Jialal, I., et al., 2013. Increased chemerin and decreased omentin-1 in both adipose tissue and plasma in nascent metabolic syndrome. The journal of clinical endocrinology and metabolism, 98 (3), E514–517. Wang, D., et al., 2013. Plasma Chemerin level in metabolic syndrome. Genetics and molecular research, 12 (4), 5986–5991. Aksan, G., et al., 2014. Association of serum chemerin levels with severity of coronary artery disease in patients with metabolic syndrome. International journal of clinical and experimental medicine, 7 (12), 5461–5468. Data availability statement
The data cited by the author in this Editorial are published in various manuscripts as referenced. However, the data from the author’s studies are available on request from the author, Professor I. Jialal and not in the public domain to respect confidentiality and protect participant privacy.